Navigation Links
Aida Files 10Q
Date:11/15/2007

SANTA MONICA, Calif., Nov. 15 /PRNewswire-FirstCall/ -- Aida Pharmaceuticals, Inc. (OTC Bulletin Board: AIDA) today announced that it has filed its form 10Q for the period ended September 30, 2007. Net revenues totaled $7,373,770 for the quarter ended 9/20/07, an increase of 5% over the same period in 2006. Gross profit decreased by 2.66% due to an increase in Costs of Goods Sold. Most notably, sales from Aida's transfusion and injection forms of etimicin sulfate increased markedly. Gross profit margins for Aida remained very strong, decreasing slightly from 55.81% to 51.75%.

Aida management expects the decrease in profits to be temporary. The Chinese pharmaceutical industry is in a state of transition due to policy changes by China's State Food and Drug Administration (SFDA). The new medicine tender system for hospitals in some areas in 2007 requires hospitals to purchase medicines and drugs directly from pharmaceutical manufacturers rather than distributors, which resulted in sales returns from some distributors. Aida has proactively and rapidly revised its distribution channels and is ready to compensate for the national policy changes. Aida also expects a strong showing from the new drugs in its pipeline that are coming to market in the coming quarters. Aida expects that these drugs will ease Aida's reliance on etimicin sulfate as a revenue generator and lessen the fluctuation in the Company's performance.

About Aida Pharmaceuticals

Aida Pharmaceuticals is a product-focused pharmaceuticals company engaged in the formulation, clinical testing, registration, manufacture, sales and marketing of advanced pharmaceutical and genetic products in mainland China. The Company's mission is to discover, develop and market meaningful new therapies that improve human health. Aida Pharmaceuticals, in operation since March 1999, is headquartered in Hangzhou, China with manufacturing, distribution and sales points throughout mainland China. Aida is GMP c
'/>"/>

SOURCE Aida Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
3. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
4. Arrow International Files and Mails Definitive Proxy Materials
5. VaxGen Files 2006 Financial Statements and Provides Cash Update
6. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
7. Anacor Files Registration Statement for Initial Public Offering
8. IsoTis Files Definitive Proxy Statement
9. Viragen Internationals Subsidiary, ViraNative AB, Files to Seek Bankruptcy Protection in Sweden
10. New Orthopedic Surgical Robotics Company Opens Its Doors; Files with the FDA for Clearance of Its Flagship Product
11. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... The Oklahoma tornado left the state ... mayor of Moore, one of the heavily damaged towns, proposed ... from cnn.com. Reaching out to also be of help, My ... Shield to counter the looming mold problem. , The ... 2013, caused 24 deaths, My Cleaning Products shared. Ten of ...
(Date:5/23/2013)... Colo. , May 23, 2013 Venaxis, ... diagnostic company focused on obtaining FDA clearance and commercializing ... today announced the pricing of an underwritten public offering ... warrants to purchase 3,500,000 shares of its common stock ... a combined public offering price of $1.25 per share ...
(Date:5/23/2013)... , May 23, 2013 PuraMed BioScience ... and marketer of over-the-counter (OTC) medicinal and healthcare ... opinion on the company based on low market ... , Non-Prescription, All Natural Product to Treat Migraine ... Outperforms #1 Prescription Competitor , Currently Available ...
(Date:5/23/2013)... LAGUNA HILLS, Calif. , May 23, 2013 /PRNewswire-USNewswire/ ... CA recently became the first hospital on ... site robotic technology. This new surgical option provides women ... Marc Winter , ... gynecologist and surgeon and medical director of minimally ...
Breaking Biology Technology:Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3
... Eisai Inc., in coordination,with the Alzheimer,s Association, announced ... Recognition of Excellence.) Pharmacy,Award. The C.A.R.E. Pharmacy ... a person with Alzheimer,s disease or a caregiver ... of those fighting this disease. The award ...
... Biotechnology Entrepreneurship program today announced it will host an angel ... , The meeting of Tech Coast ... technology and high-growth companies in Southern California, is open to ... The educational session begins at 3 pm PST on the ...
... The European autoimmune disease,diagnostics market has demonstrated ... automation. Active consolidation is occurring in the,market, promoting ... with regard to reimbursement policies for autoimmune diagnostic ... (Logo: ...
Cached Biology Technology:Eisai Inc. and the Alzheimer's Association Announce the Winner of the C.A.R.E. Pharmacy Award 2Eisai Inc. and the Alzheimer's Association Announce the Winner of the C.A.R.E. Pharmacy Award 3KGI Entrepreneur Program Hosts Angel Investing Educational Meeting 2Advances in Detection Technology Drive the European Autoimmune Disease Diagnostics Market 2Advances in Detection Technology Drive the European Autoimmune Disease Diagnostics Market 3
(Date:5/22/2013)... Researchers working to improve durability in fuel cell ... University, have discovered links between electrode degradation processes ... quantifying the effects of electrode degradation stressors in ... membrane lifetime. , The findings of the study, ... the latest in a long-term study at Burnaby-based ...
(Date:5/22/2013)... Md. (May 22, 2013)The omega 3 fatty acids in ... cardiovascular diseaseso much so that the American Heart Association ... a week, particularly fatty varieties rich in omega 3s. ... a mystery. In a new study, scientists led by ... on this phenomenon by providing evidence that fish oil ...
(Date:5/22/2013)... cellular DNA can endanger the whole organism, as they ... Ludwig-Maximilians-Universitaet (LMU) in Munich now report how byproducts of ... , The DNA in our cells controls the form ... The instructions for this are encoded in the linear ... bases adenine (A), cytosine (C), guanine (G) and thymine ...
Breaking Biology News(10 mins):Tests lead to doubling of fuel cell life 2Fish oil may help the heart beat mental stress 2DNA damage: The dark side of respiration 2
... FL -- Certain kinds of male birds gather into ... dances, and according to science, who they choose to associate ... Biologist J. Albert Uy and his collaborators finds that some ... with close male kin, than in the company of distant ...
... looking to grow their base won,t want to miss ... The summit will feature a line-up of top ... a keynote address from MIT,s Martin Schmidt, associate provost ... faculty lead for the Advanced Manufacturing Partnership (AMP), a ...
... -- Earlier today, nine university presidents representing the ... Vincent C. Gray at American University,s LEED-Gold certified ... District of Columbia Mayor,s College and University Sustainability ... the first of its kind in the nation. ...
Cached Biology News:Why birds of a feather lek together 2NJIT invites manufacturers to free summit about clean energy 2Mayor Gray, University presidents pledge to make DC the 'Greenest College Town in America' 2Mayor Gray, University presidents pledge to make DC the 'Greenest College Town in America' 3Mayor Gray, University presidents pledge to make DC the 'Greenest College Town in America' 4
... the optimization of immunostaining. ... the primary antibody, selection and ... Alk. Phos., HRP, fluorescence, or ... evaluation by light or fluorescence ...
Request Info...
Request Info...
TRIS-EDTA based buffer prepared from RNase-free water suitable for storage and dilution of siRNA, pH 8, store at 4 C ...
Biology Products: